Why we exist
Engineering the Future of Healthcare.
Panacea Stars is part of Panacea Group—a platform with one mission:
Turn breakthrough Bio-AI science into ventures that reshape healthcare.
Panacea was founded by Dr Mina Bekheet - what started as an idea in the labs of Oxford has become a global platform for venture creation—designed to meet the unique demands of health innovation.
We operate through two arms:
Our Thesis
The convergence of biology and AI is healthcare’s defining opportunity.
Biotech is unlocking new frontiers. AI is compressing timelines and supercharging discovery.
Together, they are reshaping diagnostics, therapeutics, and delivery—making medicine faster, cheaper, and more precise.
But healthcare isn’t easy. It’s slow. High-stakes. Underfunded. So we built a system to do things differently.
[Read Our Manifesto]
Why we’re here
We exist because the world needs healthcare ventures that are not only visionary—but built to last.
Too many
groundbreaking ideas never leave the lab.
brilliant scientists are left to navigate venture building alone.
founders are forced to fit a model that was never designed for the complexity of healthcare.
corporates are left watching innovation pass them by.
Heading
Dr Mina Bekheet
Dr Mina Bekheet
Chief Builder | Entrepreneur / VC | Healthtech Founder | PhD Oncology, Oxford | Backing the Convergence of Bio, AI & Human Intel
We are a collective of scientists, clinicians, engineers, operators and investors—united by a mission to redefine healthcare.
Heading
Lily Sabol
.png)
Lily Sabol
Entrepreneurship Programme Lead | MSc Social Innovation and Entrepreneurship, LSE | Venture Building for Bio-AI & Healthtech | Programme Delivery, Community Growth & Stakeholder Engagement
We are a collective of scientists, clinicians, engineers, operators and investors—united by a mission to redefine healthcare.
Heading
Dr Ross Thomson
.png)
Dr Ross Thomson
Clinical Lead | Practicing Cardiologist & PhD Cand. @ St Bartholomew's Hospital, London | Ex-Management Consultant @ BCG | MD @ Oxford University
We are a collective of scientists, clinicians, engineers, operators and investors—united by a mission to redefine healthcare.
Heading
Adam Somauroo
Adam Somauroo
Intel Lead | TechBio Strategy Consultant | McKinsey & Co. Alumnus | MSci Physics, Nottingham | Supporting Patient Impact at the Intersection of Biology and Technology
We are a collective of scientists, clinicians, engineers, operators and investors—united by a mission to redefine healthcare.
Heading
desc
desc
We are a collective of scientists, clinicians, engineers, operators and investors—united by a mission to redefine healthcare.
We are a collective of scientists, clinicians, engineers, operators and investors—united by a mission to redefine healthcare.
We exist to support:
The PhD student with a new molecular mechanism but no company.
The clinician-turned founder with an idea to transform care pathways.
The AI scientist who sees a better way to detect disease, but not yet a business model.
[Explore our programmes]
Why we excel
Because the Bio-AI revolution needs more than vision—it needs a system.
From Oxford to the world, we exist to build ventures that are scientifically rigorous, commercially viable, and clinically meaningful.
For Founders
We de-risk, support, and accelerate your journey—from early conviction to investment readiness to pre-clinical commercial scale.
For Investors
We deliver engineered deal flow—ventures that are de-risked, investment-grade, and built for healthcare’s toughest markets.
For Partners
We create bespoke ventures around unmet needs, connecting science, co-founders, and capital.
